Information generated using outcome measures to measure the effectiveness of palliative care interventions is potentially invaluable. Depending on the measurement tool employed the results can be used to monitor clinical care, carry out comparative research, provide audit data or inform purchasing decisions. However, the data collected can only ever be as good as the method used to obtain them. This review aimed to systematically identify and examine outcome measures that have been used, or proposed for use in the clinical audit of palliative care of patients with advanced cancer. Database searches were performed using MEDLINE (1991)(1992)(1993)(1994)(1995), CANCERLIT (1991CANCERLIT ( -1995, Healthplan (1985Healthplan ( -1995, and 'Oncolink' on the Internet. Further measures were located with the assistance of other professionals working in palliative care. The criteria for the inclusion and assessment of measures were a measure assessing more than one domain and a target population of advanced disease or palliative care. Fortyone measures were identified, 12 of which satisfied the inclusion criteria. These contained between five and 56 items and covered aspects of physical, psychological and spiritual domains. Each measure meets some but not all of the objectives of measurement in palliative care, and fulfils some but not all of our criteria for validity, reliability, responsiveness and appropriateness.
Introduction
In the context of health and illness, outcome is usually defined in terms of the achievement or failure to achieve desired goals. ' The measurement of the health outcome of interventions can be linked to the assessment of the appropriateness of health care interventions. 2 The use of outcome measures can therefore help determine whether a method of treatment or particular intervention package is worth while. 3 Consequently, measurement of this 'attributable effect of intervention or its lack on a previous state of health ' 4 has important implications for the purchasing of health care services.
Outcome measures in palliative care for patients with advanced cancer require the measurement of aspects that reflect the specific goals of palliative care, such as improving the quality of life before death, controlling symptoms and supporting the family. 3 Measuring the effectiveness of palliative care interventions is becoming increasingly important 6 because it allows the evaluation and development of effective and efficacious palliative care teams.
A variety of clinical audit tools and systems for palliative care have been developed in recent years, but these are being used in various ways and are constantly changing or being supplemented by new measures. This review aimed to identify and examine outcome measures that have been used, or proposed for use in the clinical audit of palliative care of patients with advanced cancer, and to systematically assess these using well-defined criteria.
Method

Sources of literature
Database searches were performed using MEDLINE (1991) (1992) (1993) (1994) (1995) , CANCERLIT (1991 CANCERLIT ( -1995 , Healthplan (1985 Healthplan ( -1995 , and 'Oncolink' on the Internet (The University of Pennsylvania Cancer Center Resource, 1994 Resource, -1996 . The search terms used, either singly or in combination, were audit, palliative care, hospice care, terminal care, clinical or medical or nursing audit, quality assurance, audit measures, assessment and outcome. Further measures were located with the assistance of a multiprofessional steering group, through personal communications with other professionals working in palliative care, and from an investigation of the grey literature. New measures published during the review period were also identified.
Inclusion criteria
The criteria for inclusion were:
1. that the target population included cancer patients, or patients with advanced disease receiving palliative care, or was considered by the authors to be appropriate for this patient group; and 2. the measure contained more than one domain; and 3. the measure could be used on patients with all cancer types.
Measures that have been used in cancer care but were specific to a particular patient group, for example, leukaemia patients (Cancer Leukaemia Group B Studies -CALGB), or measures which concentrated on only one life domain, for example, physical symptoms (McGill Pain Questionnaire), were excluded from the review (see Bowling   3 ). It was also important to identify only those measures that had been used for patients receiving palliative care or proposed for use measuring outcomes at this stage of the disease trajectory. For example, measures specifically designed to assess the outcome of nonpalliative cancer chemotherapy, such as the Breast Cancer Chemotherapy Questionnaire (BCCQ), were not included. 
Assessment of identified measures
Measures were then assessed following the criteria outlined in Table 1 ? Content validity was further assessed by whether the measure covered the particular domains reported to be relevant to palliative care (physical, psychological and spiritual dimensions), and how many items were contained in each domain.
Results
In total, 41 measures were identified (see Tables 2 and 3) . Twelve of these satisfied the inclusion criteria. These measures contained between five and 56 items and covered the physical, psychological and spiritual domains of life to differing extents (see Table 3 ).
To An initial assessment of suffering 10 This measure was developed on 259 advanced cancer patients in acute hospitals. A five-point Likert Scale with scores ranging from five for 'good' to one for 'bad' was used to record the answers to the 43 questions either by the patient unaided or by a trained nurse interviewer. The questions have been refined to give a shorter 20-item questionnaire suitable for use during the initial assessment by a member of any profession in the hospice or palliative care team.
Edmonton Symptom Assessment Schedule (ESAS) 11 The ESAS was developed for quick assessment of outcomes in routine practice. This tool consists of nine Visual Analogue Scales (VASs). The patient draws a mark along a 100 mm line corresponding to how they feel, with the far left end of the line corresponding to the least degree of symptoms, and the far right 'worst' symptoms. The ESAS is completed on admission to hospital and twice daily thereafter by the patient, or with the assistance of a nurse. Patients who are unable to respond owing to cognitive failure are assessed by their nurse or a specially trained family member. The score for each item is recorded on a bar graph, allowing staff to visualize patterns of symptom control over time. Further testing of this measure's validity and reliability are required, particularly with reference to the potential bias introduced by a change in the person recording the answers on the VAS as care continues. 12 Developed with lung cancer patients to evaluate the quality of life of those patients participating in international clinical trials, this self-reporting questionnaire is both a reliable and valid measure of the quality of life of cancer patients in research settings. Questions cover the past week and responses are mainly in the format of a straightforward four-point Likert Scale, ranging from one for 'not at all' to four for 'very much'. It contains a generic core with cancer-specific modules and work is being carried out to extend the questionnaire for Table 1 Criteria used to assess outcome measures 7 
European Organisation for Research on Cancer Treatment (EORTC QLQ-C30)
Validity -the instrument measures what it intends to measure
Content validity -does the measure cover those domains considered important? Criterion validity -does the measure correlate with superior measures or predict future outcome? Construct validity -does the measure conform with the results using other established scales (or discriminate between groups of patients)?
Reliability -the instrument produces the same results when repeated on an unchanged population
Inter-rater reliability -does the measure produce similar results when used by different observers? Test-retest reliability -does the measure produce similar results when used at different points in time?
Internal consistency -do individual items within the instrument correlate with each other?
Responsiveness to change -the instrument is able to detect clinically significant change
Has the measure demonstrated change as part of a clinical trial or cohort follow-up? Does the measure discriminate between differing degrees of disease severity? 8 Adapted from the Spitzer Quality of Life Index (a scale developed for doctors to measure the quality of life of their cancer patients), with the item activity being replaced by mobility for the older target patient group. It has not been revalidated and has been criticized for lack of responsiveness in patients with advanced disease. Ratings for each item are scored from zero to two to give a total score of 0-10 (higher scores equate to a better quality of life). It has been used to evaluate treatments and support services.
Appropriateness of format -the instrument is suitable for its intended use
McGill Quality of Life Questionnaire (MQOL) U
Developed on advanced cancer patients treated at home or in an in-patient unit, the MQOL was designed to measure overall quality of life in people with a life-threatening illness and to indicate the areas in which the patient is doing well or poorly. The patient circles a number on a ten-point categorical scale, with the extremes of least desirable and most desirable at either end. It includes an existential domain which the authors propose plays a greater role in determining quality of life in patients with local or metastatic disease than in patients with no evidence of disease.
The McMaster Quality of Life Scale (MQLS) 17
This measure was developed on 83 patients to measure the quality of life in a palliative patient population including cancer patients. Items are rated on a seven-point numerical scale with the direction of positive and negative descriptors varied. It is currently being refined and patients are now asked which ten items of the scale are most important to their quality of life.
Patients who begin to experience difficulty filling in answers are then asked to rate only these ten, most important items.
Palliative Care Assessment (PACA) 6 This measure was developed on 125 patients to assess the outcome of interventions made within two weeks of referral to a hospital palliative care team. The PACA form comprises three rating scales. Symptoms are scored on a four-point scale from zero for 'absent' to three for 'daily life dominated by the symptom', assessing the severity of each symptom from the patient's perspective, using a semi-structured interview. Insight is assessed by an observer on a five-point scale, and plans for future care were asked of the patient and recorded on a four-point scale. Facilitation of the appropriate placement for hospital patients is a fundamental element of this measure.
Palliative Care Core Standards (PCCS) 18 Originally a set of standards for in-patient hospice care and community teams, this tool has been refined and is currently being piloted in in-patient units as separate questionnaires for all those involved with the patient's well-being including the professionals, the patient and the carer. Structure, process, education and training are also covered, resulting in a comprehensive but lengthy tool at present
Rotterdam Symptom Checklist (RSCL) 14 Developed primarily as a tool to measure the symptoms reported by cancer patients participating in clinical research, this questionnaire uses a four-point Likert Scale to record responses on the bothersomeness of items over the last three days or week. Categories range from 'not at all' through to 'very much'. The authors suggest it may be useful in the evaluation of supportive care, but it may be inappropriate for patients to complete as disease advances.
19
The Support Team Assessment Schedule (STAS) 9 Developed for use with multidisciplinary cancer support teams, STAS is a validated measure of the effectiveness of palliative care. 5 Items were developed by cancer support teams to reflect the goals of palliative care. The effect of the items on the daily life of the patient over the last week is scored by a professional on a five-point Likert Scale ranging from zero for 'none' (no effect) up to four for 'overwhelming effect'. STAS is widely used in community settings and has been adapted for use in in-patient settings and to assess individual symptoms. 15 This scale was developed for patients with a life-threatening disease, either cancer or heart disease, and can be used for all types of cancer. The scale is self administered (usually in the presence of an interviewer), with responses rated on a five-point Likert Scale ranging from one for 'no distress' to five for 'extreme distress'. It concentrates mainly on the symptoms and mood in relation to quality of life.
The Symptom Distress Scale (SDS)
Schedule for the Evaluation of Individual Quality of Life (SEIQoL) 16 This measure was developed from the technique of 'judgement analysis' to measure patients' level of functioning. The measure allows respondents to nominate the five areas of life which are most important to them, rate their level of functioning or satisfaction with each, and indicate the relative importance of each area to their total quality of life. It has been tested in a variety of patient populations and healthy individuals, and has recently been reported for use clinically for patients with HTV or AIDS managed in general practice.
Discussion
In palliative care there are particular concerns about the use and relevance of outcome measures. The method of administration of a measure, whether patient-, professional-or carercompleted, is a primary concern with this patient population. The advantages and disadvantages of these various methods of recording information have been widely documented and debated. 3 " 20 In the case of patients receiving palliative care, there is an inherent difficulty using self-completion measures as many patients are too ill to complete them, or die early during care. 13 This results in a lack of information being recorded, leading to potential bias in the results because those patients likely to be experiencing the most problems are less likely to be included in data collection. As an alternative, a final assessment is sometimes completed by a professional, either before or after death. This affects the validity of a measure designed for completion by the patient. Professionally completed measures are frequently used to overcome this particular problem, but by their nature cannot accurately reflect how the patient really feels. Cohen et al. argued that the fact that only half of the palliative care population can complete a questionnaire does not mean that health care professionals should not ask those who can rate their quality of life to do so. 13 The second issue when measuring health outcome for advanced cancer patients is whether a measure includes those domains relevant to palliative care ' and does not focus on one aspect alone, be it physical symptoms (e.g. the Karnofksy Index 22 ) or the existential domain of self-content and wellbeing. The measures described above address the domains to differing extents, but no single measure covers physical, psychological and spiritual domains in a format that will provide sufficient or reliable information. The purpose of measuring the quality of life and outcomes of the care of patients is potentially fourfold. 20 One objective is to obtain more detailed information about the patient for clinical monitoring to aid and improve patient care. A second purpose is to audit the care provided, by determining whether standards are being achieved and identify potential areas for improvement. Third, research using outcome measures to compare services, or to compare care before and after the introduction of a service can be of value in assessing the efficacy of a service, and the cost-effectiveness. Finally, analysis of data generated using outcome measures can be used to inform purchasers and thereby secure resources for future services. Each of the measures described fulfils the objectives to varying degrees, but none of the measures selected successfully meets all of these, and it is questionable whether any such tool can be developed which will meet all the requirements of an 'ideal tool'. However, there is a need to continue researching and developing outcome measures in palliative care that address the concerns outlined above and that could easily be implemented into routine practice. In this way, the provision of palliative care can be monitored and we can continue to strive to obtain the best standards of patient care.
